The University of Chicago Header Logo

Connection

Michael Davidson to Receptor, ErbB-2

This is a "connection" page, showing publications Michael Davidson has written about Receptor, ErbB-2.
Connection Strength

0.115
  1. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018 10; 67(10):1780-1792.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.